ALISON JESSUP: Open Payments
NPI 1285161059 · BOURNE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 6 payments from 6 companies in 2025. Trend: 2023 $216 · 2024 $164 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 1 | $118 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $110 |
| Vanda Pharmaceuticals Inc. | 1 | $35 |
| MERZ NORTH AMERICA, INC. | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $21 |
Products named: Auvelity, CAPLYTA, FANAPT, Xeomin, AIRSUPRA, ZERBAXA.
Industry payments across MA — which companies pay providers there.
